Kwangmin Son
Principal investigator, leads PHAST CORP.
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$1.2MFederal grants as PI3 awards
3Patents grantedLatest Sep 19, 2023
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $1.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 2, 2020 | NIH | SBIR Phase I Using combinations of single-cell phenotypes for rapid antibiotic susceptibility testing | $300K | PHAST CORP |
| Aug 1, 2019 | NIH | SBIR Phase I Using combinations of single-cell phenotypes for rapid antibiotic susceptibility testing | $600K | PHAST CORP |
| Jul 29, 2019 | NIH | SBIR Phase I Using combinations of single-cell phenotypes for rapid antibiotic susceptibility testing | $300K | PHAST CORP |
4 patents as inventor
- US 10266867PHAST CORPApr 23, 2019
- US 11708596PHAST CORPJul 25, 2023
- US 11761023PHAST CORPSep 19, 2023
- US PHAST CORP—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,906
Awards as PI#927
Patents#124
Companies
- PHAST CORPLeads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.